Most Read Articles
Joy Wee, one year ago
Symptomatic rhinovirus (RV) infections in infants are associated with a decrease in bacterial diversity and higher bacterial density of the respiratory microbiota.
one year ago
Umeclidinium/vilanterol improves SGRQ total score and decreased rescue albuterol use in patients with chronic obstructive pulmonary disease (COPD), as observed in a 12-week multicentre, randomised, double-blind, parallel-group, placebo-controlled study.
one year ago
At the European Respiratory Society International Congress 2015 in Amsterdam, a panel of distinguished speakers were invited to share about targeting the respiratory tree in asthma control, with a focus on the fluticasone propionate/formoterol fixed-dose combination therapy (flutiform®, Mundipharma).
Kathlin Ambrose, one year ago
Treatment with histone deacetylase 2 (HDAC2) upregulators and rapamycin that can reverse corticosteroid resistance may improve the management of chronic obstructive pulmonary disease (COPD) and better suppress the underlying inflammation, says an expert. 

Act now for your IPF patients

one month ago
Idiopathic pulmonary fibrosis (IPF) is a disease marked by scarring and hardening of lung tissues. As a result, the lungs are unable to take in oxygen normally, which leads to lack of oxygen in the bloodstream, causing functional impairment and disability.1 Respiratory medicine experts, Professor Dr Paul W. Noble and Professor Dr Liam Chong Kin recently spoke to MIMS Doctor on IPF diagnosis and treatment. Here are the highlights from the interview.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Joy Wee, one year ago
Symptomatic rhinovirus (RV) infections in infants are associated with a decrease in bacterial diversity and higher bacterial density of the respiratory microbiota.
one year ago
Umeclidinium/vilanterol improves SGRQ total score and decreased rescue albuterol use in patients with chronic obstructive pulmonary disease (COPD), as observed in a 12-week multicentre, randomised, double-blind, parallel-group, placebo-controlled study.
one year ago
At the European Respiratory Society International Congress 2015 in Amsterdam, a panel of distinguished speakers were invited to share about targeting the respiratory tree in asthma control, with a focus on the fluticasone propionate/formoterol fixed-dose combination therapy (flutiform®, Mundipharma).
Kathlin Ambrose, one year ago
Treatment with histone deacetylase 2 (HDAC2) upregulators and rapamycin that can reverse corticosteroid resistance may improve the management of chronic obstructive pulmonary disease (COPD) and better suppress the underlying inflammation, says an expert.